Ken Griffin Lemaitre Vascular Inc Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$80.3 - $92.89 $160,600 - $185,780	2,000 Added 222.22%	2,900 $269,000
Q2 2024 Aug 14, 2024	SELL	$62.62 - $83.59 $118,978 - $158,821	-1,900 Reduced 67.86%	900 $74,000
Q1 2024 May 15, 2024	BUY	$54.0 - $71.06 $118,800 - $156,332	2,200 Added 366.67%	2,800 $185,000
Q4 2023 Feb 14, 2024	BUY	$45.37 - $58.41 $9,074 - $11,682	200 Added 50.0%	600 $34,000
Q3 2023 Nov 14, 2023	SELL	$53.45 - $67.01 $16,035 - $20,103	-300 Reduced 42.86%	400 $21,000
Q2 2023 Aug 14, 2023	SELL	$50.38 - $68.21 $45,342 - $61,388	-900 Reduced 56.25%	700 $47,000
Q1 2023 May 15, 2023	BUY	$44.73 - $51.68 $71,568 - $82,688	1,600 New	1,600 $82,000

291

20.4M

5.2K

2.9K

Ticker LMAT
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 21,962,900
Market Cap $2.04B
Description
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.